Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
RAVULIZUMAB(ULTOMIRIS)INJ:1100MG (OTHER 25395946) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved July 1, 2026 , from http://ppman.hank.ai/transparency/procedure/25395946/by-state?code_type=OTHER
“RAVULIZUMAB(ULTOMIRIS)INJ:1100MG (OTHER 25395946) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/25395946/by-state?code_type=OTHER. Accessed
July 1, 2026 .
“RAVULIZUMAB(ULTOMIRIS)INJ:1100MG (OTHER 25395946) by State,” HANK Price Transparency ,
accessed July 1, 2026 ,
http://ppman.hank.ai/transparency/procedure/25395946/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
25395946 — Ravulizumab(ultomiris)inj:1100mg
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$83,924
National median
$57,482 – $94,846
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 25395946 (OTHER), with interquartile range
State Median p25 p75
FL $83,924 $57,482 $94,846